Statistical Issues inTranslational Cancer Research : Biomarker statistics in cancer researchGEORGE, Stephen L.Clinical cancer research (Print). 2008, Vol 14, Num 19, pp 5954-5958, issn 1078-0432, 5 p.Article

Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemiaBUYSE, Marc; SQUIFFLET, Pierre; BLAISE, Didier et al.Blood. 2011, Vol 117, Num 26, pp 7007-7013, issn 0006-4971, 7 p.Article

Processes to activate phase III clinical trials in a cooperative oncology group : The case of cancer and leukemia group BDILTS, David M; SANDIER, Alan B; SCOGGINS, Maren et al.Journal of clinical oncology. 2006, Vol 24, Num 28, pp 4553-4557, issn 0732-183X, 5 p.Article

Randomized clinical trial design for assessing noninferiority when superiority is expectedFREIDLIN, Boris; KORN, Edward L; GEORGE, Stephen L et al.Journal of clinical oncology. 2007, Vol 25, Num 31, pp 5019-5023, issn 0732-183X, 5 p.Article

Impact of race on survival in men with metastatic hormone-refractory prostate cancerHALABI, Susan; SMALL, Eric J; VOGELZANG, Nicholas J et al.Urology (Ridgewood, NJ). 2004, Vol 64, Num 2, pp 212-217, issn 0090-4295, 6 p.Article

Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720BAER, Maria R; GEORGE, Stephen L; BLOOMFIELD, Clara D et al.Blood. 2002, Vol 100, Num 4, pp 1224-1232, issn 0006-4971, 9 p.Article

Recombinant Interleukin-2 in Patients Aged Younger Than 60 Years With Acute Myeloid Leukemia in First Complete Remission: Results From Cancer and Leukemia Group B 19808KOLITZ, Jonathan E; GEORGE, Stephen L; STOCK, Wendy et al.Cancer. 2014, Vol 120, Num 7, pp 1010-1017, issn 0008-543X, 8 p.Article

Low-Dose Interleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older With Acute Myeloid Leukemia in First Complete Remission : Cancer and Leukemia Group B Study 9720BAER, Maria R; GEORGE, Stephen L; ANASTASI, John et al.Journal of clinical oncology. 2008, Vol 26, Num 30, pp 4934-4939, issn 0732-183X, 6 p.Article

Satisfaction of the uncertainty principle in cancer clinical trials: retrospective cohort analysisJOFFE, Steven; HARRINGTON, David P; GEORGE, Stephen L et al.BMJ. British medical journal (International ed.). 2004, Vol 328, Num 7454, pp 1463-1466, issn 0959-8146, 4 p.Article

Fraud in medical research : An international survey of biostatisticiansRANSTAM, Jonas; BUYSE, Marc; COLTON, Theodore et al.Controlled clinical trials. 2000, Vol 21, Num 5, pp 415-427, issn 0197-2456Article

Statistical Challenges in Preprocessing in Microarray Experiments in Cancer : Biomarker statistics in cancer researchOWZAR, Kouros; BARRY, William T; JUNG, Sin-Ho et al.Clinical cancer research (Print). 2008, Vol 14, Num 19, pp 5959-5966, issn 1078-0432, 8 p.Article

Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: Final induction results of cancer and leukemia group B study 9621KOLITZ, Jonathan E; GEORGE, Stephen L; CALIGIURI, Michael A et al.Journal of clinical oncology. 2004, Vol 22, Num 21, pp 4290-4301, issn 0732-183X, 12 p.Article

The long-term clinical course of patients with cutaneous melanomaCAMEL, John W; GEORGE, Stephen L; EDWARDS, Michael J et al.Cancer. 2002, Vol 95, Num 6, pp 1286-1293, issn 0008-543XArticle

Detecting treatment-by-centre interaction in multi-centre clinical trialsPOTTHOFF, Richard F; PETERSON, Bercedis L; GEORGE, Stephen L et al.Statistics in medicine. 2001, Vol 20, Num 2, pp 193-213, issn 0277-6715Article

Duration of symptoms prior to diagnosis is related inversely to presenting disease stage in children with medulloblastomaHALPERIN, Edward C; WATSON, Dorothy M; GEORGE, Stephen L et al.Cancer. 2001, Vol 91, Num 8, pp 1444-1450, issn 0008-543XArticle